Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.29 +0.00 (+0.15%)
As of: Oct 22, 2026 · 10:55 AM EDT

Whitehawk Therapeutics (WHWK) Convertible Debt (2020)

Updated

Whitehawk Therapeutics (WHWK) reported Convertible Debt of $1.1 million for Q4 2020.

Analysis

Whitehawk Therapeutics (WHWK) Convertible Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Whitehawk Therapeutics 272.70 Mn 82.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 1.10 Mn
API Access

Whitehawk Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=WHWK&period=max&api_key=YOUR_API_KEY